Spectral AI, Inc. (MDAI)

Market Cap	56.39M
Revenue (ttm)	29.96M
Net Income (ttm)	-9.21M
Shares Out	25.75M
EPS (ttm)	-0.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	887,859
Open	2.120
Previous Close	2.100
Day's Range	2.090 - 2.260
52-Week Range	0.824 - 3.250
Beta	0.70
Analysts	Strong Buy
Price Target	4.75 (+116.9%)
Earnings Date	Aug 11, 2025

About MDAI

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. Its product, DeepView System, uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye, at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely and informed dec...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 78
• Stock Exchange: NASDAQ
• Ticker Symbol: MDAI
• Website: https://www.spectral-ai.com

Financial Performance

In 2024, Spectral AI's revenue was $29.58 million, an increase of 63.83% compared to the previous year's $18.06 million. Losses were -$15.32 million, -26.56% less than in 2023.

Analyst Forecast

According to 2 analysts, the average rating for MDAI stock is "Strong Buy." The 12-month stock price forecast is $4.75, which is an increase of 116.90% from the latest price.

Price Target

$4.75

(116.90% upside)

Analyst Consensus: Strong Buy